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ABSTRACT 
 
The antigenic trigger of sarcoidosis remains a scientific enigma, despite being the 
most common cause of interstitial lung disease. In 2010, a mouse model of 
pulmonary inflammation presented with granulomas, resembling sarcoidosis. 
Recent findings suggest the role of CD248 in inflammation and tissue 
remodelling/repair. Since these processes occur during inflammation and 
fibrogenesis, we explored the role of CD248 in a mouse model of sarcoidosis. 
            To investigate CD248 involvement in sarcoidosis, apolipoprotein knock-out 
(ApoE-/-), CD248 knock-out (CD248-/-) and double knock-out (DKO) mice were fed a 
high fat diet (HFD). Tissue histology was examined using haematoxylin and eosin 
and Van Gieson staining, and disease burden and fibrosis were quantified by Image 
J thresholding. CD248 distribution in wild type and ApoE-/- tissue sections was 
subsequently investigated by immunofluorescence. 
            ApoE deficiency combined with HFD induced sarcoid-like granulomas 
without supplementation with cholate, and our results suggest the involvement of 
CD248 in the resolution of inflammation during the development of sarcoidosis. 
CD248 deficiency influenced the severity of disease, and expression was increased 
in the sarcoid lung. 
           CD248’s capacity to influence the resolution of inflammation in sarcoidosis is 
a promising finding. Investigating CD248 deficiency in other models of inflammation 
could further elucidate its role in immunology, and potential as a therapeutic target 
in the treatment of chronic inflammatory diseases. 
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1. INTRODUCTION 
 
 
1.1  Immunopathology of sarcoidosis 
 
Sarcoidosis is a multisystem inflammatory disease, which can affect many organs 
including the liver, lymphatics, spleen and heart, but most commonly presents in the 
lung [reviewed in Patterson et al. 2012], (Figure 1). It is the most common idiopathic 
interstitial lung disease in Europe, with an prevalence of 2 cases per 10,000 people 
in the UK [Muller-Quernheim 1998]. Familial correlation of sarcoidosis has been 
suggested, with some human leukocyte antigen (HLA) genes being associated with 
disease incidence implying a possible genetic predisposition. Associated genes 
include Class I HLA 1B8, Class II HLA CRB1, & Class II HLA DQB1 [ reviewed in 
Iannuzzi et al. 2007]. The precise cause of sarcoidosis is currently unknown, but it is 
characterised by the presence of non-necrotising epitheliod granulomas in most 
cases, which persist around bronchovascular bundles and veins in the lungs during 
a cellular immune response [reviewed in Rosen 2007], (Figure 1b). Diagnosing 
sarcoidosis requires careful histological examination of biopsies from affected 
organs for the presence of sarcoid granulomas and the identification of any 
organisms which may cause granuloma formation, as the histological features of 
sarcoidosis are not unique to this condition [discussed in Mukhopadhyay & Gal 
2010]. The majority of sarcoidosis patients do not require treatment as in most 
cases, it spontaneous resolves. However, in those patients where granulomatous 
disease persists and becomes chronic, several treatment options can be 
considered. The use of immunosuppressive corticosteroids such as prednisolone is 
the most common form of treatment and can have positive results, but for end-stage 
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patients, the only remaining treatment option is lung transplantation [Iannuzzi et al. 
2007]. 
 
1.1.1 Aetiology of sarcoidosis 
 
The causative agents of sarcoidosis are controversial, but it is the general 
consensus that a specific infectious or environmental trigger is involved in 
genetically susceptible individuals. Many antigens have been put forward as being 
associated with sarcoidosis, including bacteria and chemical compounds. Possible 
bacterial triggers include propionibacteria such as P. acnes, and mycobacteria 
including M. tuberculosis [reviewed in Ichikawa et al. 2008 & Du Bois et al. 2003]. 
Compounds such as silica and even nanoparticles have also been hypothesised as 
environmental triggers [discussed in Yeager et al. 2011 & Heffner 2007]. However, 
despite numerous efforts within the research community, whether a pathogenic 
relationship exists between such agents and sarcoidosis remains unclear. 
 
1.1.2 Pathology of sarcoidosis 
 
The sarcoid granuloma is a collection of inflammatory cells and occurs following an 
immune response mounted against an unknown antigen as illustrated in Figure 2a. 
Initially, antigen presenting cells (APCs) such as dendritic cells (DCs) or 
macrophages internalise, process and present antigen to other immune cells, for 
example T cells, in the context of major histocompatability complex (MHC) class II 
[reviewed in Rosen 2007, Patterson et al. 2012 & Baughman R. P et al. 2011]. The 
T cell recognises the antigen-MHC complex via its T cell receptor (TCR) and once 
activated, begins to produce interleukin-2 (IL-2). Expression of the interleukin-2 
receptor (IL-2R) is upregulated at the lymphocyte plasma membrane. IL-2 binds to 
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its receptor and acts in an autocrine fashion, facilitating the proliferation and 
differentiation of T cells into a T helper 1 (TH1) subset [Boyman & Sprent 2012]. 
These activated T cells produce a vast array of pro-inflammatory mediators 
including interferon-gamma (IFN-γ), interleukin-12 (IL-12), interleukin-18 (IL-18) 
[Shigehara et al. 2001], macrophage inflammatory protein (MIP) and monocyte 
chemotactic protein (MCP) [Gibejova et al. 2003], which are involved in the 
activation, recruitment, and polarisation of inflammatory cells. The recruitment of 
macrophages by TH1 cells results in the local production of pro-inflammatory 
mediators such as the highly potent tumor necrosis factor-alpha (TNF-α) 
[Ferenback et al. 2003], but also IL-12 and interleukin-6 (IL-6) [discussed in Muller-
Quernheim 1998]. This facilitates the orchestration of an immune response, 
involving the infiltration of TH1 cells and macrophages to the site of inflammation. 
Here, they become organised into granulomas (Figure 1b), composed of a central 
aggregation of macrophages, which differentiate into multinucleated giant cells and 
epithelioid cells [Rosen 2007]. CD4+ T Cells can be found in the centre, with small 
numbers of CD8+ T cells, fibroblasts and B cells located at the edge [Muller-
Quernheim 1998, Patterson et al. 2012]. To date however, the role of CD8+ T cells 
and B cells in the pathology of sarcoidosis is unclear. 
 
1.1.3 Pulmonary fibrosis in the sarcoid lung 
Granuloma development in sarcoidosis may initially serve as a protective 
mechanism, encapsulating the offending inflammatory stimuli, e.g. bacteria, within 
the affected area, thus restricting further spread and resolving spontaneously in 
most cases. However inflammation can become chronic in up to 30% of individuals 
[reviewed in Lynch et al. 2007], and this protective mechanism becomes 
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dysregulated. Here, granulomas persist alongside pathological inflammation which 
causes gradual destruction of lung tissue due to the exacerbating actions of 
inflammatory cells and mediators released locally (Figure 2a). This can eventually 
lead to tissue destruction, loss of lung function and fibrosis. Pulmonary fibrosis is 
the development of excess fibrotic tissue due to fibroblast activation and 
proliferation. It is mediated by cytokines produced by inflammatory cells such as 
macrophages during chronic inflammation, including transforming growth factor-
beta (TGF-β), interleukin-1 (IL-1), interleukin-8 (IL-8) and TNF-α (Figure 2b) 
[reviewed in Coker & Laurent 1998 & Agostini & Gurrieri 2006]. During sarcoidosis, 
fibrosis is found mainly around bronchovascular bundles [Patterson et al. 2012] 
similar to granuloma distribution. This causes permanent scarring, which severely 
decreases the capacity of the lungs to oxygenate blood via the diffusion of oxygen 
from alveolar spaces into pulmonary capillaries. Ultimately, the development of 
pulmonary fibrosis in sarcoidosis can lead to death in up to 5% of patients [reviewed 
in Lynch et al. 2007 & Rosen 2007].  
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Figure 1. Representative images of normal and granulomatous lung. Formalin-
fixed murine lung tissue sections were stained with haematoxylin and eosin (H&E) 
using standard protocols. a) Normal lung section. b) Section from ApoE-/- mouse on 
HFD. Arrows indicate granuloma formation. Original magnification x20. White bar 
represents 100µm. Images are the author’s own. 
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Figure 2. Central immunopathological mechanisms involved in the 
development of sarcoidosis (a) and pulmonary fibrosis (b). 1: Antigen 
recognition by APC and migration to the LN. 2: Antigen presentation to naïve T cells 
and interaction of MHC class II with TCR stabilised by co-receptor CD4 and 
confirmed by the interaction of co-stimulatory molecules B7 and CD28. 3: T cell 
activation differentiation into TH1 subset, IL-2 production and increased IL-2R 
expression. 4: Migration of TH1s to lung followed by secretion of pro-inflammatory 
cytokines and macrophage activation and polarisation of inflammatory response. 5: 
Macrophages produce cytokines which exacerbate inflammatory response and 
cause alveolitis through increased cell recruitment and proliferation. 6: Inflammatory 
cells organise into granuloma in sarcoidosis. 7: Spontaneous resolution. 8: 
Cytokines produced by local inflammatory cells activate fibroblasts. 9: Activated 
fibroblasts secrete extracellular matrix proteins and replace normal lung 
parenchyma with fibrotic tissue. Image created in Paintbrush. 
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1.2 Current models of sarcoidosis 
 
Although a lack of understanding of the complex and dynamic immunological 
processes occurring in granuloma formation currently prevents the advancement of 
sufficient and accurate in vitro models, several in vivo models of sarcoidosis have 
been developed in attempts to uncover key antigenic stimuli, and study the 
pathological processes of sarcoidosis. 
 
i) The Kveim-Siltzbach model  
 
Developed in the 1940s, the Kveim-Siltzbach model, reviewed in Altman & Boyton 
2006, involves the inoculation of animals with sarcoid granuloma tissue extracts 
(Kveim extract). Granuloma formation in animals is representative of those seen in 
sarcoidosis, however due to the variability of conclusions drawn in laboratory 
reports, it is rare that the Kveim-Siltzbach model is used today. 
 
ii) Pathogen driven models 
Inoculation of experimental animals with granuloma-inducing pathogens may not 
accurately model sarcoidosis and assumes a pathogenic element is involved in 
aetiology, but allows the processes involved in the formation of sarcoid granulomas 
to be studied. Pathogens used in such models include P. acnes, which evokes cell-
mediated granuloma formation [Altmann & Boyton 2006]. 
 
iii) Knock-out models 
 
Selected gene knock-out (KO) models are commonly coupled with infection in order 
to induce granulomatous disease. For example, mice deficient for inflammatory 
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signalling protein MyD88 (myeloid differentiation primary response gene 88) 
infected with Schistosoma mansoni develop granuloma formation [Altmann & 
Boyton 2006, Layland et al. 2005]. However, an appealing model has recently 
emerged involving the dietary modulation and deficiency of Apolipoprotein E 
(ApoE), a protein involved in lipid metabolism, which drives granuloma formation in 
the lung without the requirement of infection [Samokhin et al. 2010], (Figure 2). 
ApoE-deficient mice on high fat diets (HFD) have been similarly used in the current 
investigation and thus the background to the model is described in more detail 
below. 
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1.3 Apolipoprotein E  
 
Apolipoprotein E (ApoE) is a key plasma lipoprotein involved in the transport and 
metabolism of lipids such as cholesterol and triglyceride [reviewed in Mahley 1988]. 
It is synthesised primarily in the liver and is a component of liver-derived very low 
density lipoprotein (VLDL), but is also produced in the periphery, for example, by 
adipocytes [reviewed in Pendse et al. 2009], and in the brain and kidney [Mahley 
1988]. ApoE serves as a ligand for low density lipoprotein (LDL) receptors [Mahley 
1988], facilitating the distribution of lipids between cells for important biological 
processes including proliferation, energy storage and the maintenance of cell 
membrane integrity. Interestingly, ApoE plays a role in immunity. It has been shown 
to possess immunosuppressive effects, and has been implicated in inflammatory 
disorders such multiple sclerosis (MS) [reviewed in Zhang et al. 2010]. ApoE 
secreted by macrophages has been shown to modulate immune responses and its 
immunosuppressive properties include down-regulating TH1 responses, 
suppressing lymphocyte proliferation and the activation of neutrophils, as well as 
inhibiting macrophage expression of pro-inflammatory cytokines [Zhang et al. 2010].  
 
1.3.1 ApoE in immunity 
ApoE is found localised to areas of tissue repair and its functions in repair and 
regeneration of tissues sheds light upon how it may function in immunological 
disorders. Injury of peripheral neurones leads to the local production of ApoE by 
macrophages following an inflammatory response [Mahley 1988]. This allows the 
distribution of lipids amongst cells as needed for biosynthesis to repair the injury 
and allow tissue regeneration to occur.  
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The detailed molecular mechanisms underlying the modulation of immunity 
by ApoE have not yet been elucidated, but initiation of signal transduction may 
occur via the binding of an ‘immunosuppressive’ receptor on the surface of T cells 
[Mahley 1988, Laskowitz et al. 2000]. It has also been hypothesised that ApoE may 
influence immune responses via nuclear factor-kappa B (NF-κB) and mitogen-
activated protein kinase (MAPK) pathways [Zhang, et al. 2010], two pathways 
involved in the up-regulation of pro-inflammatory cytokines. As previously 
mentioned, ApoE has an inhibitory effect on the expression of pro-inflammatory 
signalling molecules by macrophages and in turn, the activation of macrophages 
leads to a down-regulation of ApoE expression [Zhang et al. 2010]. This reciprocal 
effect is suggestive of a regulatory feedback system within its signalling. These 
events may not be exclusive to peripheral nervous tissue, and may be generalised 
to other damaged tissues. Certainly ApoE-deficient mice show delayed olfactory 
healing responses [Nathan et al. 2010]. ApoE-null mice have been demonstrated to 
have altered lymphocyte-mediated immune responses, and possess macrophages 
with an increased capacity to express pro-inflammatory cytokines and MHC class II 
molecules [Zhang, et al. 2010, Laskowitz et al. 2000]. The established link between 
lipid metabolism and transport, and immune regulation is strengthened by new 
evidence generated using ApoE null mice. 
 
1.3.2 The ApoE-/- model of sarcoidois 
In early 2010, Samokhin and co-workers developed a mouse model of sarcoidosis 
mentioned briefly in section 1.1.2, by placing ApoE deficient mice on cholate-
enriched HFD conditions [Samokhin et al. 2010]. These mice developed a high 
number of non-necrotising granulomas in the lungs representative of those seen in 
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human pulmonary sarcoidosis with similar immune cell compositions and induction 
of fibrosis. Interestingly this model does not incorporate a pathogen-derived 
initiating antigen as the mice are housed in sterile facilities. 
            HFD has been known to induce inflammation through increased production 
of inflammatory mediators, however ApoE-/- mice exhibit elevated lipid levels without 
the requirement of HFD [Naura et al. 2009]. Placing ApoE-/- mice on HFD has been 
shown to increase inflammation through the induction of pro-inflammatory mediators 
including TNF-α and IFN-γ [Naura et al. 2009]. Such a high-grade state of 
inflammation is likely to stimulate local generation of reactive oxygen species (ROS) 
by activated immune cells, for example macrophage production of superoxide, and 
can lead to further damage during the acute phase of lung inflammation [reviewed 
in Chabot et al. 1998], i.e. alveolitis. It is also possible that defects in immune cells, 
for example T cells, in ApoE-/- mice lead to a lack of immunosuppression or 
inhibition [Laskowitz et al. 2000], resulting in an impaired ability to prevent or repair 
injury. Such conditions could lead to chronic inflammatory states which promote 
granuloma development, and lead to pathological occurrences e.g. fibrogenesis. 
The mechanism which drives fibrogenesis in this model remains to be characterised 
but is hypothesised to involve a switch to TH2-driven immune responses. 
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1.4 The role of CD248 in fibrosis and immune responses 
 
CD248 is a transmembrane glycoprotein also known as endosialin or tumor 
endothelial marker-1 (TEM-1), with a controversial cellular expression pattern. It is 
widely considered as a stromal cell marker and its expression has been 
demonstrated on fibroblasts, pericytes, smooth muscle cells and mesenchymal 
stem cells (MSCs) in vitro [Christian et al. 2008]. The precise physiological role of 
CD248 is still unclear however research strongly suggests a central role in tissue 
remodelling and repair. Expression is high during embryogenesis; a period of 
intense remodelling, and decreases to virtually no expression in adults [Christian et 
al. 2008, Macfadyen et al. 2007]. However CD248-null mice develop normally with 
appropriate wound healing capacities and fertility [Nanda et al. 2006], suggesting 
the involvement of other compensatory factors in these circumstances. CD248 has 
been a prime candidate as a tumour endothelial marker (TEM) in recent research. It 
is up-regulated in many cancers including breast [Macfadyen et al. 2005] and colon 
[Christian et al. 2008] carcinomas. High expression within tumours is of significance 
since these represent areas of high levels of cell proliferation, remodelling, 
adhesion, and in the case of metastasis, migration. This supports the hypothesis 
that CD248 plays a key role in these processes. 
 
1.4.1 CD248 and the extracellular matrix 
CD248 has been shown to interact with extracellular matrix proteins such as 
collagen (types I and IV), and fibronectin [Tomkowicz et al. 2007]. The ability to bind 
extracellular matrix proteins is vital in cell adhesion and migration, required for 
tissue development and repair. Blocking CD248 has been shown to inhibit pericyte 
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migration [Bagley et al. 2008], suggesting that CD248 is also involved in 
angiogenesis due to the supportive function of pericytes to the vasculature, further 
demonstrating the importance of CD248 expression in tissue development and 
remodelling. In addition to this, fibroblast migration, which is important for efficient 
wound healing, is also reduced by removing CD248 expression [Christian et al. 
2008]. Although important for physiological wound repair, there is also evidence that 
CD248+ fibroblasts are linked to fibrogenesis in disease. For example, during 
chronic kidney disease, stromal fibroblasts show increased expression of CD248 
which correlates with disease stage [Smith et al. 2011]. Similarly in lung fibrosis, 
extracellular matrix proteins are deposited to replace the normal lung parenchyma 
and CD248 has been demonstrated to bind to them. Thus CD248 may be important 
in the development of fibrosis in the chronic stage of sarcoidosis as well as having 
an involvement in the initiating immune response. 
 
1.4.2 CD248 in inflammatory disease 
The involvement of CD248 in the chronic inflammatory disease rheumatoid arthritis 
(RA) was highlighted by Maia and co-workers [Maia et al. 2010]. They 
demonstrated that CD248 expression increased within the human synovium during 
RA and that the severity of rheumatoid arthritis in murine models was reduced by 
deletion of the cytoplasmic domain of CD248. As intracellular domains are typically 
involved in signalling, this implies that the reduction in severity was due to effects 
downstream of CD248. Possible signalling roles of CD248 are supported by studies 
showing that CD248 regulates cell proliferation [Lax et al. 2010], via platelet-derived 
growth factor-receptor (PDGF-R)-dependent signalling [Tomkowicz et al. 2010]. 
Therefore CD248-dependent modulation of cellular responses may be key to the 
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pathogenesis of chronic inflammatory diseases such as RA and sarcoidosis. 
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1.5 Aim and objectives 
 
Sarcoidosis is the most common cause of idiopathic lung disease in Europe [Muller-
Quernheim 1998]. Despite the identification of immunological features in 
sarcoidosis, the molecular mechanisms underlying its pathology remain poorly 
understood. ApoE knockout (ApoE-/-) mice fed HFD develop lung injury reflective of 
the clinical picture of sarcoidosis, and inactivation of CD248 has been shown to 
reduce the severity of rheumatoid arthritis, a chronic inflammatory disease. 
Therefore, we developed an ApoE-null CD248-null double knockout mouse (DKO) 
to uncover the role of CD248. Our major experimental aim was to explore the role of 
CD248 in a mouse model of sarcoidosis. To achieve this we had several 
experimental objectives:  
 
• To investigate whether high fat diet alone (in the absence of cholate 
supplementation) is sufficient to cause sarcoid-like lesions in the mouse lung 
 
• To examine whether absence of CD248 influences the severity of sarcoidosis 
in the ApoE-/- mouse 
 
• To characterise the distribution of CD248 in wild type (WT) and ApoE-/- 
animals 
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2. METHODS 
 
2.1 Animals and experimental protocol 
ApoE-null (ApoE-/-) CD248-null (CD248-/-), and ApoE-null/CD248-null (DKO) 
C57BL/6 mice (bred in house under specific pathogen free (SPF) conditions: 
Biomedical Sciences Unit, University of Birmingham) were taken off a normal chow 
diet and placed on a high fat diet (HFD) containing 0.15% supplementary 
cholesterol (Western RD Diet, Special Diets Services, Essex, UK) after 10 weeks of 
birth. 13 weeks following this change, mice were sacrificed by terminal anaesthesia. 
Control groups remained on a normal chow diet. The number of mice per group 
differed but all consisted of at least 10 animals (Table 1). All tissue was collected 
under the appropriate Home Office licence. 
 
Table 1. Numbers of mice in each experimental group. A total of 76 10-week old 
WT, CD248-/-, ApoE-/- and DKO mice were placed on normal chow diet or HFD for 
13 weeks. ApoE-/- and DKO mice on chow were unavailable for use in this 
investigation. 
 
Group Number of mice per group 
WT on chow     11 
WT on HFD 15 
  CD248-/- on chow 11 
CD248-/- on HFD 15 
ApoE-/- on HFD 10 
DKO on HFD 14 
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2.2 Tissue preparation 
Lungs were fixed in 10% formal saline for a minimum of 48h and paraffin embedded 
using standard procedures. Sections were cut at 4µm using a microtome and 
mounted on Xtra glass slides (Leica Biosystems, UK). On occasion spleens and 
livers were also collected from the animals for use as positive control samples. 
 
2.3 Histology 
Haematoxylin and eosin (H&E), and Van Gieson stains were performed on sections 
from all tissue samples within each group using standard protocols. Standard 
histological assessment of morphology was performed using a routine H&E staining 
protocol. Here, de-waxed sections were raised in dH2O stained in haematoxylin for 
4 minutes, in 0.3% acid alcohol for 30 seconds, tap water for 5 minutes and eosin 
for 2 minutes with intermittent 5-minute tap water rinses between each step. Finally 
Sections were then dehydrated rapidly in alcohols, cleared and mounted in DPX. 
Van Geison staining was used to quantify the +extent of fibrotic change. After de-
waxing sections were stained with Celestin Blue for 5 minutes, rinsed in dH2O and 
stained in Mayer’s haematoxylin for 5 minutes. Sections were washed well in running 
tap water for 5 minutes and flooded with Van Gieson stain for 5 minutes. Sections 
were then dehydrated and mounted as before. All reagents were sourced from 
Leica Biosystems and slides were analysed using bright field microscopy. 9 images 
of each section were taken, with emphasis on bronchovascular bundles wherever 
possible. Images were subsequently analysed using Image J software (see section 
2.5). 
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2.4 Immunofluorescence 
Anti-CD248 antibody (Abcam) was used to determine CD248 expression in WT and 
ApoE-/- lung tissue sections. Formalin-fixed paraffin embedded tissue sections were 
de-waxed and re-hydrated. Antigen retrieval was performed using a microwave and 
EDTA buffer. Sections were blocked with 10% casein for 30 minutes followed by 
10% goat serum for 30 minutes, and incubated with anti-CD248 antibody overnight 
at 4oC. Sections were then washed for 5 minutes in Tris-buffered saline (TBS) 3 
times before incubation with a FITC-conjugated secondary antibody (eBioscience) 
for 1h. Sections were washed again as before, stained with DAPI, and mounted in 
prolong gold (Invitrogen). All antibodies were used according to manufacturers 
instructions. For negative controls, the primary antibody was omitted and TBS used 
in its place. Images were captured by confocal microscopy using an inverted Zeiss 
LSM-510 UV confocal microscope at x10 magnification. 
 
2.5  Data handling and statistical analysis 
Nuclei in H&E stained sections and collagen in Van Gieson stained sections were 
quantified using Image J software via use of the colour threshold tool. This 
quantified the percentage of the total area stained for nuclei or collagen, indicating 
% disease burden or % fibrotic area. Statistical significance was determined using 
GraphPad Prism version 5.0 by performing a one-way analysis of variance 
(ANOVA). The mean ± the standard error of the mean (SEM) was calculated from 
data obtained and P=<0.05 was considered to be statistically significant. 
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3. RESULTS 
3.1 High fat diets induce lung inflammation in WT and CD248-/- 
mice 
 
The main histological feature of sarcoidosis is the formation of granulomas. H&E 
staining was used to examine the prevalence of inflammatory cells in tissue 
sections from the lungs of WT or KO mice on a normal chow-fed diet or HFD. 
          H&E staining revealed normal lung histology in chow-fed WT and CD248-/- 
mice (Figure 3a & 3c). Bronchovascular bundles and alveolar structures were 
normal in appearance and size in both mouse strains. They occurred at similar 
frequency in both WT and KO animals and no significant accumulations of 
inflammatory cells were present in either genotype on normal chow. In contrast, 
small aggregates of cells with similar morphology to granulomas were observed in a 
number of tissue sections from WT and CD248-/- mice on HFD (Figure 3b & 3d). 
These were discrete and localised in proximity to the vessels within the lungs. No 
other gross morphological features were associated with consumption of HFD.  
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Figure 3. High fat diets induce inflammation in WT and CD248-/- mice. 
Representative images of formalin-fixed murine lung tissue stained with 
haematoxylin and eosin (H&E) using standard protocols. Sections from 10-15 
animals per group were analysed (see Table 1). (a) WT on chow, (b) WT on HFD, 
(c) CD248-/- on chow, (d) CD248-/- on HFD, (e) ApoE-/- on HFD, and (f) DKO on 
HFD. Bright field microscopy was used at x20 original magnification and bar 
represents 100µm. Black arrows represent granuloma formation, while red arrow 
indicates infiltration by inflammatory cells. 
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3.2  Inflammatory lung injury is exacerbated in ApoE-/- mice, and 
CD248 deficiency reduces this response 
 
On examination of tissue sections from Apo E-/- mice on HFD, large aggregates of 
cells with the morphology of inflammatory cells were observed reminiscent of 
sarcoid granulomas (Figure 3e). These aggregates appeared at a much higher 
frequency and density than those seen in the lungs of WT and CD248-/- mice on 
HFD. Additionally we noted occasional brown pigmentation in ApoE-/- mice on HFD, 
possibly representing hemosiderin uptake by macrophages. Interestingly, DKO mice 
exhibited very few, if any, such lesions and these lungs appeared histologically 
similar to chow-fed WT or CD248-/- mice (Figure 3f). It is notable that in all animals 
the majority of cell aggregates were located around bronchovascular bundles, as 
seen in figures 3b, 3d & 3e. 
            Images were then analysed using the threshold tool on Image J software to 
quantify the extent of granuloma formation (Figure 4). Where granulomas persist, 
an increase in haematoxylin-stained nuclei will be seen representing an increase in 
infiltrating inflammatory cells, therefore resulting in a higher % threshold. Although a 
small number of granulomas were observed in WT HFD mice, this was not 
statistically significant compared to WT mice on chow. No significant difference was 
seen between CD248-/- and WT mice on chow. CD248-/- mice on HFD had 
significantly increased numbers of lesions compared to WT mice on chow 
(P=<0.005). Disease burden was further increased in ApoE-/- mice on HFD 
compared to chow-fed WT (P=<0.005). Importantly the increase of disease burden 
in ApoE-/- mice on HFD was not apparent in DKO animals where disease burden 
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was not statistically significant from WT mice on chow. 
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Figure 4. Percentage disease burden in histological images from mice on 
chow or HFD. Sections from 10-15 animals per group were imaged (See Table 1). 
WT, CD248-/- (CD248 KO), ApoE-/- (ApoE DKO) and double knock out (DKO) mice 
on chow-fed diets or HFD were stained with H&E, imaged using bright field 
microscopy and the percentage area of stained nuclei was analysed using Image J 
threshold analysis. Data represents mean ± SEM of 9 images from each mouse 
sample. ANOVA was used to compare all groups to WT chow. ***=P<0.0005, 
*=P<0.05 
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3.3 Assessment of lung fibrosis using Van Gieson staining 
suggests that CD248 is involved in lung fibrogenesis 
 
In chronic inflammatory diseases such as sarcoidosis, fibrosis can occur involving 
the deposition of extracellular matrix proteins, including collagen, by activated 
fibroblasts. Here, Van Gieson staining was used to identify collagen in our lung 
sections. As expected, WT mice on chow-fed diets had no abnormal collagen 
staining, and appeared histologically similar to CD248-/- mice on chow (Figure 5a & 
5c). In contrast large collagen deposits were noted in tissue samples from WT 
(Figure 5b) and ApoE-/- mice on HFD (Figure 5e). Interestingly CD248-/- mice on 
HFD presented with a lower degree of staining (Figure 5d). Unexpectedly, DKO 
mice on HFD exhibited the most intense collagen staining representing prominent 
fibrotic lesions (Figure 5f). In all mice fed HFD, fibrosis persisted mainly around 
bronchovascular bundles, similar to the granuloma distribution observed in H&E-
stained tissue sections. 
            Again, Image J thresholding was used to quantify the extent of fibrosis in 
histological images (Figure 6). Where fibrotic lesions occur, intense pink staining will 
be seen demonstrating collagen. Therefore, the more pink-stained collagen, the 
higher the % threshold will be, representing the % fibrotic area. Collagen staining in 
tissue sections from WT and CD248-/- chow-fed mice was similarly low in both 
groups. Compared to WT mice on chow, the % fibrotic area was higher in WT 
(79.05% increase), CD248-/- (36.12% increase) and ApoE-/- mice on HFD (68.84% 
increase). We confirmed that levels of fibrosis were highest in DKO animals on 
HFD, and this change was statistically significant compared to animals on WT Chow 
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(P=<0.005). The fibrotic area in these animals increased by 176.45%, which 
corresponds well with the microscopic analysis. 
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Figure 5. Assessment of lung fibrosis using Van Gieson staining suggests the 
involvement of CD248 in lung fibrogenesis. Representative images of formalin-
fixed murine lung tissue sections stained with Van Gieson reagents using standard 
protocols. Sections from between 10 and 15 animals were anaylsed (See Table 1). 
(a) WT on chow, (b) WT on HFD, (c) CD248-/- on chow, (d) CD248-/- on HFD, (e) 
ApoE-/- on HFD, and (f) DKO on HFD. Pink staining localises to areas of collagen 
deposition. Images were photographed by bright field microscopy at x20 
magnification and analysed by Image J threshold analysis. 
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Figure 6. Percentage fibrotic area in histological images from mice on Chow 
or HFD. Sections from between 10 to 15 WT, CD248-/- (CD248 KO), Apo E-/- (Apo E 
KO) and double knock out (DKO) mice on chow-fed diet or HFD (see table 1) were 
Van Gieson-stained, imaged by bright field microscopy at x20 magnification, and 
the percentage area of stained collagen was analysed using Image J. Data 
represents mean ± SEM from 9 images per mouse sample. ANOVA performed on 
all groups compared to WT mice on chow revealed a significant difference between 
DKO mice on HFD and WT mice on chow (***=P<0.0005).  
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3.4 Assessment of pulmonary distribution of CD248 using 
immunofluoresent staining  
 
Following the observation that fewer inflammatory infiltrates occurred in DKO mice 
on HFD, yet extensive fibrosis was evident in these animals, the distribution of 
CD248 was investigated in WT and ApoE-/- mice by immunofluorescence (Figure 7). 
Little immunofluorescent staining was visible in WT mice on chow, except for a 
minor quantity around a vessel (Figure 7a). More abundant staining was evident in 
sections from WT mice on HFD, and appeared to be evenly distributed throughout 
the tissue. Of note, some autofluorescence or non-specific staining was seen 
around vessels in controls (Figure 7b). Strong staining was observed in tissue 
sections from ApoE-/- mice on HFD, and followed a similar distribution to that seen 
in WT mice on HFD, however staining was much more prominent in sections from 
ApoE-/- mice on HFD (Figure 7c). 
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Figure 7. Assessment of pulmonary distribution of CD248 using 
immunofluorescent staining. Representative immunofluorescent images of 
formalin-fixed murine lung tissue sections. Samples from 5 WT Chow (a), WT HFD 
(b), and ApoE-/- HFD (c) mice were stained with anti-CD248 antibody followed by a 
FITC-conjugated secondary and analysed by confocal microscopy at x10 
magnification. Grey staining represents nuclear counterstain (DAPI). Controls for 
each genotype were created by omitting the primary antibody, and the same 
acquisition settings were re-used when imaging all sections. Arrow indicates 
aggregate, V = vessels, B = bronchioles, A= alveolar space. White bar represents 
100µm. 
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4. DISCUSSION 
 
Granuloma formation occurs as a normal immunological mechanism to confine 
potential infectious agents identified by their immunostimulatory antigens. This 
protective process can become dysregulated in chronic immune responses, leading 
to pulmonary fibrosis, a key predisposing factor to death in sarcoidosis patients 
[reviewed in Baughman & Lower 2011]. Samohkin and co-workers recently 
described a mouse model of sarcoidosis [Samohkin et. al 2010], providing a novel 
means to study sarcoid granuloma formation and associated pathological features 
such as fibrosis. In this study, the role of CD248 in a similar model of sarcoidosis 
was investigated. 
 
4.1  HFD is sufficient to induce sarcoid-like lung lesions in ApoE-/- 
but not DKO mice 
 
In order to investigate the effects of CD248 in sarcoidosis, a mouse model similar to 
that previously developed by Samohkin and co-workers [Samohkin et. al 2010] was 
used. The model used in this investigation did not involve supplementation with 
cholate in the diet but we have demonstrated that HFD alone is sufficient to induce 
sarcoid-like granuloma formation in ApoE-/- mice. 
            The disease burden representing granuloma formation in CD248-/- mice on 
chow was not statistically different from WT mice on the same diet and lung 
histology was similar. This suggests that CD248 deficiency in mice on a standard 
diet does not appear to affect normal lung parenchyma, and may relate to our 
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observations that there is minimal expression of CD248 in WT mice on chow diet 
(Figure 7a). However, HFD was sufficient to induce the formation of granulomas in 
the lungs of WT, CD248-/- and ApoE-/- mice. This is of interest as Samohkin et al. 
2010, did not see granuloma formation in WT mice on HFD without cholate 
supplementation. Cholate has been shown to induce inflammation in mice through 
the induction of pro-inflammatory genes [Quin et al. 2005]. This discrepancy could 
be due to the fact that the mice in our investigation remained on HFD for 13 weeks 
starting at 10 weeks of age, whereas the mice in the study by Samohkin and 
colleagues had HFD for 16 weeks but started the diet younger (6 weeks). Absence 
of requirement for cholate supplementation in our study to induce granuloma 
formation likely reflects genetic differences influencing the immune system between 
WT DBA1/J mice on HFD used in the investigation by Samohkin et al., compared to 
the WT C57/BL6 background used in this study.  
            HFD induces inflammation in many organs including the colon and brain 
[Ding et al. 2010, Erdelyi et al. 2009, Pistell et al. 2010], and absence of granulomas 
in our chow-fed mice suggest it also contributes to pulmonary granuloma formation. 
Similarly our CD248-/- mice on HFD presented with more inflammatory aggregates 
than chow-fed WT mice, demonstrating that deficiency of this gene does not inhibit 
granuloma formation in the HFD mouse model. 
            ApoE-/- mice on HFD exhibited more extensive granuloma formation with 
occasional brown pigmentation near vessels potentially as a result of hemosiderin 
uptake by macrophages due to local haemorrhage, caused by severe inflammation 
(Figure 3e). ApoE-/- mice on HFD are used as a model to study inflammatory 
diseases, such as atherosclerosis [reviewed in Hofker et al. 1998], where by 
disease is accelerated by the inflammatory environment. Therefore the 
	  	   33 
exacerbating effects of ApoE-/- on granuloma formation are also possibly due to the 
inflammatory state seen with this phenotype on HFD. ApoE has been known to play 
many roles in immunity, including inhibition of lymphocyte proliferation [Laskowitz et 
al. 2000]. A lack of such immunosuppressive properties may contribute to 
granuloma formation, through the exaggeration of ordinary inflammatory responses, 
which under normal circumstances are protective and controlled mechanisms. 
Levels of circulating lipids are elevated in ApoE-/- mice [Moghadasian et al. 2001] 
which may make exacerbate inflammation itself, for example hyperlipidaemia is 
known to contribute to the inflammatory process which initiates and accelerates the 
chronic inflammatory disease atherosclerosis [reviewed in Steinberg 2002]. 
            Unlike our study, in the study by Samohkin and co-workers, no granulomas 
presented in ApoE-/- mice after 16 weeks on HFD without cholate supplementation 
in the diet. This lack of granuloma formation may be due to the substantial 
difference in time on HFD compared to our study (10 week difference), with 
resolution of granulomas in ApoE-/- mice possibly occurring in the remaining 6 
weeks of feeding HFD. 
            Surprisingly, DKO mice on HFD demonstrated reduced granuloma 
formation. The phenotype seen in ApoE-/- mice on HFD appeared alleviated in DKO 
mice and was phenotypical of WT Chow. This suggests that CD248 may contribute 
to the formation of granulomas in some way. Although the role of CD248 in 
immunity is poorly understood, it has been shown to promote inflammation [Maia et. 
al 2010] and there is a strong link between its expression and tissue 
remodelling/repair, possibly providing an explanation for why its deficiency appears 
to alleviate granuloma formation. 
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4.2  Absence of CD248 influences the severity of fibrosis in 
sarcoidosis. 
 
Following the confirmation of granuloma formation in HFD animals, the extent of 
fibrosis in these animals was investigated. Fibrosis occurs as a result of chronic 
inflammation and can act as a means of resolution or can itself become chronic and 
dysregulated, driving further injury. Thus assessment of fibrosis may provide an 
indication of disease severity. 
          As expected, no abnormal Van Gieson staining was seen in WT and CD248-/- 
mice on chow fed diets and collagen deposition in CD248-/- mice was not 
statistically significant from WT mice, indicating the absence of fibrotic lesions. This 
correlates with the data seen in our H&E analysis, where few, if any granulomas 
were present. Low levels of collagen staining were evident in WT and CD248-/- mice 
on HFD, but were not statistically significant compared to chow-fed WT mice, and 
most likely corresponded to the granuloma formation seen in Figures 3 & 4. In 
contrast, large deposits of collagen were observed in ApoE-/- mice on HFD 
representing extensive fibrosis. This result was expected due to the size and 
complexity of inflammatory aggregates suggesting a state of chronic inflammation. 
Such chronic inflammatory events can commonly lead to the development of 
fibrosis due to cytokines in the environment released by immune cells, for example 
macrophage production of TGF-β, activating fibroblasts and stimulating collagen 
production. 
            Samohkin and co-workers did not find granulomas in ApoE-/- mice on HFD 
but did observe fibrosis. This was noted to be comparable to levels seen in ApoE-/- 
mice on cholate-supplemeted HFD after just 8 weeks [Samohkin et al. 2010]. It is 
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likely that the inflammatory properties of cholate previously described are 
exacerbating inflammation and thus, the formation of fibrosis. This data also 
supports our suggestion that granulomas may have occurred at an earlier time 
point, but all which remains is evidence of resolution and remodelling post-injury. 
            DKO mice on HFD exhibited the most prominent fibrosis, which was highly 
statistically significant compared to WT animals on chow. This was a very 
unexpected result, as almost no granulomas were observed on analysis of H&E-
stained sections. Although the H&E analysis suggested that no disease was 
evident, analysis of Van Gieson-stained tissue sections suggested otherwise. 
Fibrosis occurs as a result of injury or inflammation, where a preceding 
inflammatory response is followed by the development of fibrotic lesions. Deletion of 
CD248 may have resulted in acceleration of this fibrotic process, or increased 
speed of resolution of granulomas, as opposed to prevention of disease. CD248 
has been shown to interact with many extracellular matrix proteins [Tomkowicz et 
al. 2007], which may mediate interactions involved in normal inflammation between 
fibroblasts and immune cells. Our results suggest that the degree of fibrosis varies 
depending on granuloma severity in mice on HFD, but is affected by deficiency of 
CD248. Here, lack of CD248 may result in insufficient communication with immune 
cells, leading to immune cell dysfunction. 
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4.3  CD248 is not expressed in the lungs of chow-fed WT mice, 
but is up-regulated in sarcoidosis. 
 
Granuloma formation was not observed in H&E data from DKO mice, however 
widespread fibrosis was evident following further investigation by Van Gieson-
staining. The involvement of CD248 in the lung was therefore investigated by 
examining its distribution using anti-CD248 antibody. 
            Immunofluorescent staining for CD248 suggested that this surface protein is 
not normally expressed in the lungs of WT mice on chow-fed diets. Christian and 
co-workers describe little or no expression of CD248 in many organs in the adult 
[Christian et. al 2008], supporting this observation. CD248 expression was however 
observed in WT mice on HFD. Since HFD is pro-inflammatory and induced 
granuloma formation, this suggests increased CD248 expression due to 
inflammatory activation. This is supported by Lax and co-workers, who found 
increased CD248 expression in inflamed spleen [Lax et al. 2007]. Since the role of 
CD248 is concerned with fibroblast remodelling/repair of tissues, upregulation in the 
context of injury seems feasible. 
            A minor quantity of staining was seen around a vessel in Figure 7a. Some 
autofluorescence or non-specific staining for the secondary antibody was seen 
around a vessel in the control section for Figure 7b, suggesting that the small 
amount of staining seen in a) was most likely non-specific. 
            Our results implied that CD248 expression is increased by ApoE deficiency. 
CD248 staining appeared stronger in chronic inflammation in the ApoE-/- model of 
sarcoidosis, suggesting expression of even higher levels of CD248 by cells, most 
likely fibroblasts, than in WT mice on HFD. Further supporting this, the expression 
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of CD248 correlates with the level of disease burden (and therefore inflammation) 
seen in WT mice on chow, WT mice on HFD and ApoE-/- mice on HFD. Thus where 
very few, if any inflammatory aggregates were present in tissue sections, low levels 
of CD248 were observed, and where more severe inflammation was present, 
expression was increased. This correlates with reported expression patterns 
associated with severity of sarcomas [Bagley et al. 2008] and chronic kidney 
disease [Smith et al. 2011]. Interestingly the fact that the distribution of CD248 
expression in inflamed (WT mice on HFD and ApoE-/- mice on HFD) tissues was 
similar, suggests that it is probably the same cells in both models which express 
CD248, and that either cell number or degree of expression per cell increases with 
disease severity. 
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4.4  Conclusion & Future implications 
 
Granulomas form as a result of inflammation, and are often the result of treatable 
pathogens. The cause of sarcoidosis however remains an enigma. Our results and 
others [Samhokin et al. 2010], demonstrate that ApoE deficiency and HFD 
exacerbates inflammation, being sufficient to cause sarcoid-like lesions. However, 
we have shown that cholate in the diet is not required for this. We have also 
demonstrated that CD248 is involved in the pathology of sarcoidosis, influencing the 
severity of disease, as demonstrated in other chronic inflammatory diseases [Maia 
et al. 2010], although the cause of this effect is not clear. In our model, H&E 
analysis suggested that CD248 prevented granuloma formation, however the 
formation of fibrosis strongly suggests otherwise. Therefore, CD248 is most likely to 
be increasing the speed of disease progression, possibly through dysregulation of 
immune cells, promoting resolution. At this stage, it is not possible to determine the 
extent to which CD248 deletion increases the speed of granuloma formation, or the 
scope of fibrosis. In order to do this, different time courses would need to be 
analysed, ideally alongside lung function tests to confirm that granuloma formation 
and fibrosis correlate with in vivo observations of decreased lung function. 
            Despite achieving our aim to explore the role of CD248 in a mouse model of 
sarcoidosis, limitations of this study included a lack of control ApoE-/- and DKO mice 
on chow due to time restraints. This prevented the confirmation of observations 
from these genotypes. In addition to this, groups did not contain equal numbers of 
mice, possibly introducing statistical bias in smaller groups.  
            The role of CD248 in inflammation and fibrosis could be further investigated 
though CD248 deficiency in other mouse models of inflammation, and collection of 
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brochoalveolar lavarge fluid (BAL) from these animals to examine the present 
cytokine profile. The cellular makeup of granulomas could be identified through 
immunoflourescent staining to confirm their similarity to those found in sarcoidosis, 
and use of an isotype-matched control antibody could exclude non-specific staining 
of anti-CD248 antibody. Co-localisation of CD248 with specific markers of CD248-
expressing cells such as fibroblasts, could uncover which cells were expressing 
CD248 in the lung. Subsequent real-time PCR could be used to quantify and 
compare CD248 expression in these cells in animals on normal chow diet or HFD. 
            The development of new models of CD248-deficient chronic inflammatory 
diseases will aid our comprehension of the pathological processes involved in 
granuloma formation and fibrosis. Such models may elaborate our understanding of 
the involvement of CD248 in disease and resolution, possibly leading to novel 
therapeutic targets/strategies in the future. 
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ABSTRACT 
 
It is widely acknowledged that stromal cells play a key role in the homeostasis of 
lymphocytes in the lymph node (LN). Recent findings showed that LN stromal cells 
are derived from adipocyte precursor cells residing in the fat pad surrounding the 
LN. Interestingly, the adipose tissue is rich in lymphocytes but factors regulating 
their recruitment and retention are unknown. We thus assessed whether adipose 
tissue-derived stromal cells (ASCs) could play a role in the survival of lymphocytes 
in the adipose tissue. 
            To investigate the relationship between lymphocyte survival and ASCs, 
lymphocyte survival under different culture conditions with stromal cells was 
examined using flow cytometry, and expression of important lymphotrophic factors 
such as interleukin-7 (IL-7) and chemokine (C-C motif) ligand 19 (CCL19) was 
investigated with real-time PCR (RT-PCR). 
            Our findings suggest that pre-adipocytes in the stromal vascular fraction 
(SVF) of adipose tissue produce IL-7 and CCL19 contributing to T lymphocyte 
survival in vitro, however a cocktail of survival factors is likely to be involved in vivo. 
            The capacity of pre-adipocytes to modulate T cell survival is an important 
finding for adipose tissue biology. Although the reason for this physiological 
occurrence is unknown, a better understanding of how adipose tissue influences 
immune responses may lead to the development of novel anti-inflammatory 
therapies in cell-mediated diseases and obesity. 
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1. INTRODUCTION 
 
1.1 Structure and Function of Lymph Nodes 
 
Secondary lymphoid organs (SLOs), such as lymph nodes (LNs), play a key role in 
the initiation of adaptive immunity. They are positioned along the lymphatic vessels 
at specific sites of the body. The lymphatic vasculature allows the drainage of small 
molecules, immune cells such as antigen-bearing dendritic cells (DCs), potential 
pathogens and antigens from surrounding tissues and organs via lymphatic vessels 
into the LNs. Recirculating lymphocytes enter the LN from the blood by 
extravasation at post-capillary venules known as high endothelial venules (HEVs) 
[reviewed in Willard Mack 2006]. The highly specialised structure of the LN enables 
antigen presentation, recognition, and the induction of appropriate immune 
responses. Communication between antigen presenting cells (APCs), T cells and B 
cells is crucial for the onset of an adaptive immune response. 
            The LNs consist of distinct regions within a surrounding capsule (Figure 1), 
with a highly specialised stromal architecture. The stroma is a supportive network of 
tissue comprised of stromal cells originally found to provide structural support to 
tissues and organs. However, these cells have since been shown to play additional 
roles in immunity. The importance of stromal cells in the development of the LN and 
other lymphoid organs has been recognised [Mebius 2003, Cupedo & Mebius 
2004], along with their many other functions, including their ability to secrete 
homeostatic factors influencing the lymphocyte pool. So far, five stromal cell 
populations have been identified in LNs; Gp38+ CD31- fibroblastic reticular cells 
(FRCs), Gp38+ CD35+ follicular dendritic cells (FDCs), Gp38- CD31+ blood 
endothelial cells (BECs), Gp38+ CD31+ lymphatic endothelial cells (LECs) and 
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RANKL+ (Receptor activator of nuclear factor kappa-B ligand) marginal reticular 
cells (MRCs) [Link et al. 2007, Mueller & Germain 2009]. Lymphoid tissue stromal 
cells play an important part in the orchestration of immune responses, forming an 
intricate 3D meshwork and supporting maximal immune cell interactions through 
organisation of lymphocytes in the LN [reviewed in Mueller & Germain 2009, and 
Roozendaal & Mebius 2011], ensuring correct locations for interaction with their 
cognate antigen. The regions of the LN each perform individual functions, ultimately 
working together to provide an optimal microenvironment for lymphocytes to 
encounter and respond to antigens where necessary.  
 
1.1.1 The Subcapsular Sinus 
The subcapsular sinus (SCS), as it’s name suggests, is located directly below the 
LN capsule and is the site at which lymph is delivered to the LN by afferent 
lymphatic vessels, and exits via efferent lymphatic vessels on the opposing side 
[reviewed in Mueller & Germain 2009].  Macrophages reside in the SCS, sampling 
antigen as it passes though in the lymph [Mueller & Germain 2009]. 
            Also associated in this zone are a stromal cell population known as marginal 
reticular cells (MRCs), which form a layer beneath the SCS and express common 
stromal markers [Mueller & Germain 2009]. It is hypothesised that these cells 
represent a remaining population of lymphoid tissue organiser cells (LTo) from LN 
development [Katakai et al. 2008]. However, little is known about their true 
functionality. 
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1.1.2 The Cortex 
Beneath the SCS is the cortex, which is composed mainly of B lymphocytes 
organised into primary follicles. These primary follicles become secondary follicles 
following antigen stimulation, and germinal centres are formed within, representing 
areas of high B cell proliferation [reviewed in Willard-Mack 2006, and Mueller & 
Germain 2009].  
            Within the cortex resides the stromal cell subset of follicular dendritic cells 
(FDCs) which interact with B cells and form a supportive network within B cell 
follicles in which B cells can locate their cognate antigen. To facilitate this, FDCs 
express C-X-C motif chemokine 13 (CXCL13), a B cell chemoattractant, and high 
levels of cell adhesion molecules (CAMs) such as vascular cell adhesion molecule-
1 (VCAM-1) and mucosal addressin cell adhesion molecule 1 (MAdCAM1) 
[reviewed in Mueller & Germain 2009]. 
	  
1.1.3 The Paracortex 
 
The paracortex is located between the cortex and medulla, and is populated 
predominantly by T cells and DCs [Mueller & Germain 2009]. It is here that T cells 
look for their cognate antigen presented by DCs and proliferate in response to it.  
            Fibroblastic reticular cells (FRCs) can be located in the paracortex, and it is 
these stromal cells which surround HEVs. They are the main source of interleukin-7 
(IL-7) in the LN and also secrete the chemokine CCL19 (chemokine (C-C motif) 
ligand 19)  [Link et al. 2007, Mueller & Ahmed 2008], two key mediators of naïve T 
lymphocyte survival and homeostasis of the T cell population within the paracortex. 
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1.1.4 The Medulla 
Finally, the innermost region of the LN is the medulla, an area consisting mainly of 
plasma cells. Plasma cell precursors known as immunoblasts mature in the 
medulla, having migrated from germinal centres (GCs) in the cortex, and secrete 
antibodies into the lymph [Willard-Mack 2006].  
            Medullary fibroblasts constitute the stromal network alongside a scaffold of 
reticular fibres that support the structure of the LN [Mueller & Germain 2009]. 
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Figure 1. The structure of lymph nodes. Antigen enters LN via lymph in afferent 
lymphatics or migrating APCs in blood via HEVs. Antigen is processed and 
presented in the context of major histocompatibility complex (MHC) class II in cortex 
and paracortex. Communication between T cells, B cells and APCs leads to 
migration and proliferation of lymphocytes in the paracortex (T cells) or primary 
follicles in cortex to give rise to germinal centres (B cells). Activated B cells migrate 
to the medulla, where they mature into plasma cells and secrete antibodies into the 
lymph, which exits via the efferent lymphatic vessel to re-circulate the body. Image 
created in Paintbrush.  
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1.2  Lymph Node Development  
 
LN organogenesis occurs in the embryo and crosstalk interactions between 
lymphoid tissue inducer (LTi) cells and stromal organiser cells known as lymphoid 
tissue organisers (LTo) cells, is essential for the later stages of formation of these 
organs [White et al. 2007]. 
LTi cells express the TNF ligand family member Lymphotoxin (LT), and are found 
early on in LN organogenesis. Binding of LT to its Lymphotoxin Beta receptor 
(LTβR) expressed by stromal organiser cells activates the classical and alternative 
nuclear factor kappa-B (NF-κB) signalling pathways, resulting in the up-regulation of 
important CAMs, cytokines and chemokines [briefly reviewed in Cupedo & Mebius 
2004]. It is these factors, which ultimately direct the formation of LNs, through the 
attraction, retainment, and organisation of haemopoietic cells within the developing 
LN anlagen. 
LTβR signalling is essential for LN organogenesis as shown by the absence of 
these organs in mice deficient in this receptor or its downstream signalling 
molecules. A recent report has shown that stimulation through LTβR and the 
alternative (NF-κB2/RelB) pathway is required for full maturation of stromal cells to 
become “organizer” cells that express high levels of VCAM-1, intercellular adhesion 
molecule-1 (ICAM-1) and MAdCAM-1 and cytokines including IL-7 [Bénézech et al. 
2010]. 
            IL-7 can upregulate LT expression, and is involved in the regulation of the 
LTi cell pool, essential for LN formation, and the importance of this cytokine is 
demonstrated by the fact that IL-7 deficient mice have defective development of 
peripheral LNs [reviewed in Huang & Luther 2012]. Therefore, the expression of 
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genes induced though LTβR signalling leads to the recruitment of immune cells and 
the organisation of specific areas in the LN required for functional adaptive 
immunity. 
 
1.3  The relationship between adipose tissue and lymph nodes 
 
In past years, adipose tissue was originally regarded as a site of energy storage 
and release as triglycerides and fatty acids respectively, supplying cells with 
provisions for growth. Like stromal cells, subsequent research has uncovered the 
function of adipose tissue to be more elaborate than initially thought. Now, adipose 
tissue is widely considered as an endocrine organ with involvement in immunity 
[reviewed in Schaffler et al. 2007]. 
            The cellular constituents of adipose tissue include adipocytes, pre-
adipocytes, fibroblasts, endothelial cells, and immune cells such as macrophages 
and lymphocytes [Schaffler & Buchler 2007, Cawthorn et al. 2012]. The stromal cell 
compartment of adipose tissue can be found in the stromal vascular fraction (SVF) 
following collagenase digest [Schaffler & Buchler 2007]. 
	  
1.3.1 Immune Functions of adipose tissue 
 
The most obvious function of adipose tissue in immunity is the provision of energy 
to support inflammatory reactions and precursors of mediators such as cytokines 
and chemokines. Adipose tissue is slowly emerging as having greater and more 
complex involvements in immunity, including interactions with immune cells such as 
CD4+ T cells and macrophages through the expression of cytokines, adipokines, 
and cell surface proteins. 
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       Tumor necrosis factor alpha (TNF-α) is produced primarily by adipocytes in 
adipose tissue and is a potent pro-inflammatory mediator, activating macrophages 
and other immune cells. Interleukin (IL-6) is also produced by adipocytes, and 
contributes to the pro-inflammatory response through its involvement in the 
proliferation and differentiation of lymphocytes, but can also be anti-inflammatory as 
it activates IL-10 expression [reviewed in Rondinone C. M. 2006]. IL-10 is an anti-
inflammatory cytokine that downregulates the expression of pro-inflammatory 
mediators and inhibits signalling though pro-inflammatory pathways such as NF-κB. 
Leptin and Adiponectin are adipokines produced by adipose tissue. Leptin is able to 
influence T cell proliferation, activation and apoptosis as well as modulating 
macrophage activities through directing the increased release of MCSF 
(macrophage colony-stimulating factor) in adipose tissues [Rondinone C. M. 2006]. 
Adiponectin modulates cytokine expression by exerting anti-inflammatory effects 
through decreasing the production of TNF-α and IL-6, whilst increasing IL-10 
release [Rondinone C. M. 2006]. 
            The capacity of adipose tissues to produce inflammatory mediators is further 
demonstrated in obesity and related pathologies, where an excess of adipose tissue 
results in a low grade state of chronic inflammation [reviewed in Lee & Pratley 
2005], and the fact that most LNs are surrounded by adipose tissue (for example 
the inguinal (iLN), mesenteric (mLN), and popliteal LNs [Pond 2003]), supports the 
concept of its association with immunity.  
 
1.3.2 Pre-adipocytes 
 
Pre-adipocytes are fibroblastic adipose tissue-derived stromal cells of mesenchymal 
origin, representing adipose precursor cells. These cells have been previously 
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identified as Sca1+ CD31- CD45- [Rodeheffer et. al 2008]. Mesenchymal stem cells 
(MSCs) are a pluripotent cell population with the capacity to differentiate into 
several different cell lineages including osteoblasts, chondrocytes, myocytes and 
adipocytes [reviewed in Schaffler & Buchler 2007]. In this study, adipose tissue-
derived stromal cells will be abbreviated to ASCs, which resemble adipose tissue-
derived stem cells [reviewed in Cawthorn et al. 2012]. ASCs are multipotent, and 
like MSCs, can also differentiate into osteoblasts, chondrocytes, myocytes and 
adipocytes. It has been suggested that ASCs are equivalent to bone marrow MSCs, 
and share cell surface markers [Cawthorn et al. 2012]. 
            As mentioned, pre-adipocytes are able to differentiate into adipocytes, 
through a process called adipogenesis. During adipogenesis, MSCs differentiate 
into adipose precursors (pre-adipocytes), which are then able to give rise to 
adipocytes. This process of differentiation involves the expression of transcription 
factors including CCAAT/enhancer binding proteins (C/EBPs), peroxisome 
proliferator-activated receptor gamma (PPARγ), and their target genes such as 
adiponectin [discussed in Berger J. P. 2005]. 
            In addition to adipocytes, pre-adipocytes are also able to express cytokines 
and chemokines. This includes factors which are involved in lymphocyte 
homeostasis, such as IL-7 and CCL19 [Meijer et al. 2011]. Gp38+ CD31- CD45- 
stromal cells (FRCs) are the main source of IL-7 in the LN [Link et al. 2007, Mueller 
& Ahmed 2008], and pre-adipocytes in the SVF of adipose tissue are able to 
produce IL-7. Rodeheffer and co-workers identified pre-adipocytes through lack of 
CD31 and CD45 expression [Rodheffer et al. 2008], and adipocyte precursors have 
been identified in the Gp38+ CD31- fraction of adipocyte derived SVF [Bénézech et 
al. 2012]. Therefore, we hypothesised that pre-adipocytes in the SVF of adipose 
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tissue could be sorted on the basis of Gp38 expression and lack of CD31 and CD45 
expression, and may also have supportive or regulatory functions towards SLOs, 
similar to that of LN FRCs. Increasing evidence for this comes from Bénézech and 
co-workers, who demonstrated that a common progenitor cell with pre-adipocyte 
characteristics can give rise to LN stroma, and confirmed that pre-adipocytes have 
the capacity to migrate to LN and contribute to the different stromal cell subsets in 
vivo [Bénézech et al. 2012].  
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1.4 IL-7 and LTβR signalling 
 
The pattern of gene expression by cells determines their function and allows them 
to respond to their environment accordingly. Signal transduction is central to the 
control of gene expression in all cells, and governs the means by which 
physiological processes occur. In order to comprehend such behaviour, it is first 
important to understand the key molecular mechanisms underlying them. 
 
1.4.1 IL-7 signalling pathway 
 
IL-7 is a 25 kDa protein belonging to the haematopoietic family of cytokines [Huang 
& Luther 2012]. Its expression by non-haematopoietic cells such as LN stromal cells 
is a critical factor in the proliferation and survival of lymphocytes, in particular T 
cells. 
IL-7 is the ligand for the interleukin-7 receptor (IL-7R), a heterodimer formed from 
an alpha chain (IL-7Rα) and a gamma chain (IL-7γc).  Lymphocytes are one of the 
main cell types expressing both chains of the IL-7R, probably due to their 
requirement of IL-7 for survival [Huang & Luther 2012]. The IL-7R signals via the 
Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway 
(Figure 2a). Following the ligation of the IL-7R by soluble IL-7, JAK 1 and JAK 3 
bind to the intracellular domain of the α and γc chains respectively, causing them to 
dimerise. Subsequent autophosphorylation of the JAKs results in signal 
transduction. Target proteins include proteins involved in survival (e.g. Bcl-2) and 
proliferation (e.g. PI3K). The transcription factor STAT5 homo-dimerises on 
activation and translocates to the nucleus where it binds DNA and influences gene 
expression, such as CIS (cytokine-induced Src homology 2-containing protein), 
which is involved in the negative regulation of cytokines, and the chemotactic 
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cytokine MIP-1α  (M protein 1 alpha) [Nelson et al. 2004], however many of 
STAT5’s targets remain unknown. 
 
1.4.2 LTβR signalling pathway 
 
The Lymphotoxin Beta Receptor (LTβR) is a type 1 transmembrane glycoprotein 
belonging to the TNF-Receptor Superfamily of proteins [reviewed in Schneider et al. 
2004]. LTβR is expressed on the surface of many cell types such as stromal cells, 
but not on lymphocytes [reviewed in Browning J. L. 2008]. Although LTβR has more 
than one ligand, LT will be focussed on due to its relevance to this investigation. LT 
is expressed on the surface of activated lymphocytes and is comprised of an α 
subunit and two β subunits, often being referred to as LTα1β2 [Schneider et al. 
2004].  
The binding of LT to LTβR initiates the activation of the NF-κB family of transcription 
factors; the classical (canonical) NF-κB pathway or the alternative (non-canonical) 
NF-κB pathway (Figure 2b). In the classical NF-κB pathway, ligation of the LTβR 
leads to the interaction of TNF receptor associated factor (TRAF) adaptor proteins 
with the intracellular domain of the receptor, which leads to the mobilisation of NF-
κB1 heterodimer (p50/RelA), enabling its translocation into the nucleus where it 
mediates the expression of genes involved in pro-inflammatory responses including 
MIP-1β (macrophage inflammatory protein-1B) and VCAM-1 [reviewed in Schneider 
et al. 2004 & Oeckinghaus et al. 2011]. 
In the alternative NF-κB pathway TRAFs are recruited to the LTβR like in the 
classical pathway however this leads to the activation of NIK (NF-κB-inducing 
kinase) instead of the IKK (inhibitor of NF-κB kinase) complex, resulting this time in 
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the translocation of the NF-κB2 (p52/RelB) heterodimers to the nucleus where they 
upregulate genes involved in lymphoid organ formation and organisation [Schneider 
et al. 2004], for example CCL19 and IL-7 [Bénézech et al. 2012]. 
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Figure 2. IL-7 and LTβR signalling. (a) IL-7/IL-7R signalling pathway. IL-7 binds to 
the IL-7R, causing the α chain and γc chain to recruit JAK1 and JAK3 respectively 
[Iwanami et al. 2011]. Autophosphorylation of the JAKs leads to the recruitment of 
STAT5 or activation of the PI3K pathway. On recruitment, STATs become 
phosphorylated and homodimerise, leading to their translocation to the nucleus 
where they bind DNA and alter gene expression. On stimulation of the PI3K 
pathway, AKT is activated, and leads to the regulation of proteins involved in 
survival and proliferation [Jiang et al. 2005].  
(b) LT/LTβR signalling pathway. Ligation of LTβR by LT can lead to signalling via 
classical or alternative NF-κB pathways following the recruitment of TRAFs. In the 
classical NF-κB pathway, receptor activation results in the phosphorylation of IκB 
(inhibitor of κB) by the IKK complex (IκB kinase complex), releasing the NF-κB1 
(p50/RelA) dimer and allowing its translocation into the nucleus, where genes 
involved in cell homeostasis and immunity are regulated [Schneider et al. 2004]. In 
the alternative pathway, NIK activates IKKα, leading to the phosphorylation of NF-
κB1-induced p100, followed by its processing in the proteasome into p52. p52 then 
translocates to the nucleus with RelB as an NF-κB2 heterodimer [Oeckinghaus et 
al. 2011]. Image created in Paintbrush. 
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1.5 Aim & Objectives 
In recent years, the importance of ASCs has slowly emerged and we now 
understand them to play an important role in the development and regulation of 
immunity. However much more is yet to be known regarding the embryonic origin of 
ASCs, and their role in the regulation of lymphocyte survival in the adult. 
Understanding the contribution of adult pre-adipocytes in the modulation and 
survival of immune cells may hold potential applications in obesity or chronic 
inflammatory diseases involving adipose tissue. Investigating their properties will 
lead to an increased understanding about lymphocyte homeostasis by adipose 
tissue, and fat as an immunological organ. 
Aim: 
• To investigate the relationship between ASCs and lymphocyte survival 
Objectives: 
• Determine the role of ASCs in lymphocyte survival 
 
• Examine the contribution of the LTβR pathway in lymphocyte survival 
 
• Explore the involvement of IL-7 in lymphocyte survival 
 
• Ascertain cell composition of adipose tissue SVF from WT and LTβR-/- mice. 
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2.  METHODS 
2.1  Mice 
WT and LTβR-/- mice on a C57BL/6 background were bred in the University of 
Birmingham’s Biomedical Services Unit (Birmingham, UK) under specific pathogen 
free (SPF) conditions, and in accordance with Home Office regulations. Mice were 
culled via CO2 asphyxiation between 10 and 15 weeks of age. 
 
2.2 Isolation of ASCs from adipose tissue and cell culture 
Inguinal fat pads from age-matched mice were dissected and lymph nodes removed 
from WT tissues. Tissue was digested using RPMI with 2% FCS, 2.5mg/mL 
Collagenase D (Roche) and 100µg/mL DNase I (Sigma) for up to 20 minutes with 
constant shaking at 37oC. Cells were passed through a cell strainer, and the 
resulting cell suspension was centrifuged yielding a pellet representing the SVF. 
Cells were cultured in RPMI 1640 medium containing 10mM HEPES buffer (Sigma), 
50IU/mL penicillin, 50µg/mL streptomycin, (PAA) and 50µM b-mercaptoethanol with 
10% FBS, (Sigma) and incubated at 37oC. 
            For survival assays, WT or LTβR-/- SVF cells were seeded in triplicate at 
density of 1 million per well in 48-well plates and washed daily for 48h to remove 
non-adherent cells. After 5 days when SVF cells were approximately 30% confluent, 
fresh lymphocytes from disaggregated WT mLN were seeded at a density of 1 
million per well. This was considered day 0. Lymphocyte survival was analysed by 
flow cytometry of non-adherent lymphocytes after 0, 1, 2, 4 and 7 days in co-culture, 
and calculated as a percentage of cells in the live gate. 
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2.3 Fluorescent antibody cell sorting (FACS) of pre-adipocytes 
for IL-7 investigation 
WT SVF cells were stained with CD31, Gp38 and CD45 (eBioscience), 
disaggregated and sorted using MoFlo (Dako Cytomation) cell sorter (Figure 6a). 
Gp38+ CD31- CD45- pre-adipocytes were seeded in triplicate at a density of 1 
million per well in 48 well plates and washed after 24 and 48h to remove non-
adherent cells. After 72h (Day 0), lymphocytes from disaggregated WT mLN were 
seeded at 1 million per well, accompanied by either 40µg/mL anti-IL-7Rα antibody 
(R&D systems) or 0.1µg/mL IL-7 (eBioscience)(Table 1). Cells were incubated at 
37oC and non-adherent lymphocytes analysed on day 2 by flow cytometry, following 
cell counting using Trypan blue dye exclusion to determine live cell numbers. 
Calculations were performed as a percentage of total live cells per well. 
 
 Table 1. Culture conditions for IL-7 investigation. Pre-adipocytes and/or mLN 
lymphocytes were seeded at 1 million per well in a 48-well plate, and treated with 
anti-IL-7Rα antibody, IL-7, or neither. After 2 days, lymphocyte survival was 
analysed by flow cytometry (Figure 6b). 
  A B C D E 
1 Pre-adipocytes + lymphocytes 
Pre-adipocytes 
+ lymphocytes 
+ anti-IL-7Rα 
Lymphocytes Lymphocytes + anti-IL-7Rα 
Lymphocytes + 
IL-7 
2 Pre-adipocytes + lymphocytes 
Pre-adipocytes 
+ lymphocytes 
+ anti-IL-7Rα 
Lymphocytes Lymphocytes + anti-IL-7Rα 
Lymphocytes + 
IL-7 
3 Pre-adipocytes + lymphocytes 
Pre-adipocytes 
+ lymphocytes 
+ anti-IL-7Rα 
Lymphocytes Lymphocytes + anti-IL-7Rα 
Lymphocytes + 
IL-7 
	  	   64 
 2.4 Flow cytometry 
Lymphocytes were stained with CD8a, CD19, CD62-L and CD4, and SVF cells 
stained with CD31, Gp38 and CD45. Flow cytometry was performed using a FACS 
Calibur (BD Biosciences), and analysed using FlowJo software (Tree Star). Non-
viable cells were stained with fixable viability dye eFluor780 to be excluded from the 
live gate using forward scatter (FSC)/side scatter (SSC) gates. All antibodies/dyes 
purchased from eBioscience and used according to manufacturer’s instructions. 
 
2.5 Real-time PCR 
cDNA was prepared from WT and LTΒR-/- SVF cells and adipocytes using µMacs 
One-Step cDNA Synthesis Kit (Miltenyi Biotec) according to manufacturer 
instructions. Primers for IL-7 and CCL19 were used, alongside β-actin as a 
reference gene. Real-time PCR (RT-PCR) was performed using an Applied 
Biosystems 7900HT system and means from triplicate reactions ± SEM multiplied 
by 1000 were taken. Data represents a single experiment. 
 
2.6 Statistical analysis 
Statistical significance was calculated for all survival assays using GraphPad Prism 
5. An unpaired t-test was performed and mean ± SEM was determined. P=<0.05 
was considered statistically significant 
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3.  RESULTS 
3.1  Survival of lymphocytes in co-culture with WT ASCs 
 
In order to establish the role of ASCs in the survival of lymphocytes, lymphocytes 
were co-cultured with stromal cells from inguinal fat pads of WT mice for 7 days. To 
determine lymphocyte survival, naïve CD4+ CD8+, and CD19+ lymphocytes in the 
live gate were quantified using flow cytometry (Figure 3a).  
            By day 4, almost all B and T cells cultured alone had died (Figure 3a & 3b). 
For this reason, day 4 will be used as a key point of comparison in the analysis of 
these survival experiments. Survival was significantly higher on day 2 (P=<0.01) 
and day 4 (P=<0.05) for both T and B cells cultured with ASCs, when compared to 
being cultured alone (Figure 3b). Survival of CD4+ T cells was also seen to be 
statistically significant on day 7 (P=<0.01) compared to single culture, suggesting 
that CD4+ T cells survive better than CD8+ T cells or B cells in co-culture with ASCs. 
A drop in survival of 28.5% and 39.3% for CD4+ and CD8+ T cells respectively 
supports this observation (Figure 3b). By day 7, CD4+ T cell survival had decreased 
by 36%, and CD8+ cells had decreased by 69.5%. B cell survival appeared to be 
least effected by co-culture with ASCs. 
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Figure 3. Lymphocyte survival in co-culture with ASCs. (a) Representative 
images of flow cytometric analysis performed on lymphocytes following antibody 
staining for lymphocyte markers. Live cells were gated on (first column) and then 
separated on the basis of naivety (CD62-L), and the expression of either CD19, 
CD4 or CD8a. (b) The survival of B cells, CD4+ T cells and CD8+ T cells in co-
culture with ASCs derived from the SVF of inguinal fat pads of WT mice (red - with 
stroma) or alone (black – without stroma). Survival was determined as a percentage 
of cells in the live gate and expressed as the mean ± SEM of triplicates from one 
experiment. Statistical significance between single culture and co-culture was 
determined for days 2, 4 and 7. **= P<0.01, *=P<0.05.  
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3.2 Ability of LTβR-/- stromal cells to support lymphocyte survival 
 
LTβR is a key factor governing the differentiation of stromal cells in the LN. We thus 
tested its role in ASCs in supporting T cell survival. Again, flow cytometry was used 
to quantify the survival of CD19+, CD4+ and CD8+ lymphocytes in the live gate and 
stromal cells isolated from inguinal fat pads of LTβR -/- mice were used in co-culture 
(Figure 4a). 
            As shown above, lymphocyte survival decreased rapidly when cells were 
cultured alone and almost all cells were no longer viable by day 4 (Figure 4b). 
Lymphocytes co-cultured with WT ASCs presented with the highest levels of 
survival, and these results were statistically significant when compared to the 
survival of lymphocytes in the presence of LTβR-/- ASCs at day 4 and day 7 for B 
cells (Day 4: P=<0.01, Day 7: P=<0.05), CD4+ T cells (Day 4: P=<0.05, Day 7: 
P=<0.01) and CD8+ T cells (Day 4: P=0.05, Day 7: P =0.01). However, the survival 
of lymphocytes in co-culture with LTβR-/- ASCs was still higher than lymphocytes 
cultured alone, and was statistically significant on day 4 for B cells (P=<0.05), days 
2, 4 and 7 for CD4+ T cells (P =<0.005, 0.05 & 0.01 respectively), and days 2 and 4 
for CD8+ T cells (P=<0.01 & 0.05 respectively). T cells appeared to survive better on 
day 4 than B cells in all co-culture conditions, with the least decrease in survival 
from CD4+ T cells in co-culture with both WT (64.7%) and LTβR-/- (83.7%) ASCs, 
and the biggest decrease in B cells with WT (87.9%) and LTβR-/- (94.4%) ASC. 
CD4+ T cells survived the best in both WT and LTβR-/- co-cultures on day 7, 
continuing to be statistically significant in LTβR-/- co-cultures compared to single 
cultures (P=<0.01), and WT co-cultures compared to LTβR-/- co-cultures (P=<0.01).  
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Collectively, these results suggest a defect of LTβR-/- ASCs to sustain 
lymphocyte survival when compared to WT ASCs. However, LTβR-/- cells are not 
completely impaired as lymphocyte survival is still higher in co-culture assays than 
in the absence of ASCs. T cells, in particular CD4+ cells, appeared most influenced 
by ASCs in terms of survival, with B cell survival being influenced the least.  
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Figure 4. Lymphocyte survival in co-culture with WT and LTβR-/- ASCs. (a) 
Representative images of flow cytometric analysis of antibody-stained lymphocytes 
on day 0 and 4. (b) Survival of B and T lymphocytes in co-culture with ASCs (blue 
and red) or single culture (black). Survival was determined as a percentage of cells 
in the live gate (Figure (a), first column) and expressed as the mean ± SEM of 
triplicates from one experiment. Statistical significance between single culture and 
co-culture was determined for days 2, 4 and 7. Diamonds(♦) represent statistical 
comparison between LTβR-/- ASC co-culture vs. without stroma, and asterisks(*) 
represents statistical comparison between  WT vs. LTβR-/- ASC co-culture. 
Statistical significance calculated for 2, 4 and 7 days. ♦♦♦=P<0.005, ♦♦/**= 
P<0.01, ♦/*=P<0.05. 
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3.3 Survival of T lymphocytes on adipose tissue-derived stromal 
cells is dependent on IL-7 
 
Following the observation that ASCs express IL-7 (Figure 5a), the effect of this 
homeostatic cytokine on the survival of lymphocytes in co-culture with pre-
adipocytes was next investigated using anti-IL-7Rα antibody, which binds to the α 
chain of the IL-7 receptor, inhibiting signalling. Initially, pre-adipocytes were sorted 
(Figure 6a). Then, WT lymphocytes were cultured alone or with sorted Gp38+ CD31- 
CD45- pre-adipocytes and treated with IL-7 or anti IL-7Rα (Figure 6b). Day 2 was 
chosen as the point of analysis because the previous survival experiments 
demonstrated that cells in single culture were almost all dead by day 4 (Figures 3a, 
3b, 4a & 4b) thereby making day 2 the best comparison point for analysis of any 
variations in survival. 
            T cell survival was 11.8% higher for CD4+ T cells and 16.8% higher for CD8+ 
T cells in co-cultures with sorted pre-adipocytes, compared to being cultured alone, 
and was statistically significant for CD8+ T cells (P=<0.005), confirming that pre-
adipocytes influence T lymphocyte survival, in particular CD8+ T cells. B cell survival 
did not appear to be influenced by the presence of pre-adipocytes, IL-7 or anti-IL-
7Rα antibody, and no statistical significance in survival was seen between 
experimental conditions and cells alone. As a positive control, IL-7 was added to 
lymphocytes cultured alone to demonstrate its effects on survival. Despite having no 
significant effect on B cells, IL-7 substantially increased T lymphocyte survival with 
statistical significance of P=<0.01 for CD4+ cells, and P=<0.005 for CD8+ cells 
compared to cells alone with anti-IL-7Ra, although these levels do not represent in 
vivo levels, as IL-7 was used at a higher concentration than physiologically normal. 
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Addition of anti-IL-7Rα antibody inhibited CD4+ and CD8+ T cell survival by 15.5% 
and 11.4% respectively compared with pre-adipocyte co-culture, and was 
statistically significant in both cases (P=<0.05). However, inhibiting IL-7 in cells 
alone did not completely abolish survival, suggesting the involvement of factors 
other than IL-7 in lymphocyte survival. 
             Next, the expression of IL-7 and CCL19 in the Gp38+ fraction of SVF (pre-
adipocytes) was measured by RT-PCR to determine whether adipose tissue-
derived pre-adipocytes were the ASCs producing the survival factors as these cells 
have been shown to produce them in the LN. Both IL-7 and CCL19 were found to 
be expressed by the Gp38+ CD31- CD45- fraction of cells isolated from inguinal fat 
pads of WT mice (Figure 6c). Levels of both IL-7 and CCL19 expression were much 
higher than seen in the LN, however this is most likely due to the fact that the only 
cells producing significant amounts of IL-7 in the LN are FRCs, and the Gp38+ 
CD31- CD45- fraction was purified thereby yielding more cells in the Gp38+ fraction, 
hence greater expression. 
 
 
 
 
 
 
	  	   72 
3.4 Expression of LTβR is not necessary for IL-7 expression 
 
Since IL-7 and CCL19 are the main factors involved in lymphocyte survival 
expressed by LN stromal cells, the expression of these cytokines by cells in adipose 
tissue was investigated. 
            IL-7 and CCL19 were expressed in both the SVF of adipose tissue and 
adipocyte fractions of adipose tissue from WT and LTβR-/- mice (Figure 5). 
Expression of both of these survival factors did not differ greatly between SVF and 
adipocyte fractions. IL-7 expression in both fractions was comparable to that seen in 
the LN (Figure 5a), suggesting similar levels of lymphocyte homeostasis in both 
organs, whereas CCL19 expression was lower than in the LN (Figure 5b). 
Surprisingly, LTβR-/- SVF and adipocyte fractions expressed the same levels of IL-7 
and CCL19. 
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Figure 5. The expression of IL-7 and CCL19 in WT and LTβR-/- adipose tissue. 
IL-7 (a) and CCL19 (b) expression in SVF and adipocyte fraction of WT and LTβR-/- 
adipose tissue was determined via RT-PCR, using β-actin as reference gene. WT 
LN extract was analysed to provide a point of comparison of expression. Data is 
expressed as a mean of the relative expression from triplicate reactions in one 
experiment.   
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Figure 6. The effects of IL-7 on lymphocyte survival and its expression in pre-
adipocytes. (a) WT SVF cells were stained and Gp38+ CD31- CD45- pre-
adipocytes sorted. (b) Lymphocytes were treated with anti-IL-7Rα antibody on day 0 
and analysed on day 2 by flow cytometry. The percentage of surviving lymphocytes 
was calculated from a viable cell count and data represents the mean ± SEM from 
one triplicate experiment. (c) RT-PCR was performed to determine the expression 
of IL-7 and CCL19 in Gp38+ SVF cells. LN extract was run alongside for comparison 
and β-actin was again used as a reference gene. This data is representative of 
triplicate reactions from a single experiment.***=P<0.005, **=P<0.01, *=P<0.05, 
NS=not statistically significant.  
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3.5 Stromal cell compositions in WT and LTβR-/- SVF derived 
from inguinal adipose tissue. 
 
Finally, in order to investigate whether differences in stromal cell populations were 
responsible for the discrepancies seen in survival between WT and LTβR-/- SVFs, 
the cellular composition of the SVF from adipose tissue of WT and LTβR-/- mice was 
analysed. Flow cytometric analysis of SVF was conducted following staining for 
CD31, Gp38 and CD45, which have been previously described as markers of 
stromal cell populations [Link et al. 2007]. Similar percentages of cells were seen in 
all gates, except for the Gp38+ CD31- gate, representing pre-adipocytes. In the  
LTβR-/- SVF, 57.1% of cells were observed in this gate (Figure 7b) compared to WT 
SVF (44.3%, Figure 7a), suggesting a slight difference in pre-adipocyte frequency. 
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Figure 7. SVF cell composition. Representative images from  flow cytometric 
analysis of 3 WT and 3 LTβR-/- SVFs.  SVF cells derived from (a) WT and (b) LTβR-
/- inguinal fat pads were stained for CD31, Gp38 and CD45 expression. Non-viable 
cells were excluded from the live cell gate using FSC/SSC gates. CD45- cells were 
gated on, and three stromal cell populations were identified here, assuming the 
Gp38+ CD31- population to represent pre-adipocytes. 
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4.  DISCUSSION 
 
Lymphocyte homeostasis is crucial in SLOs. The maintenance and organisation of a 
lymphocyte pool by stromal cells enables appropriate immune responses, and 
therefore a functional immune system. Gp38+ CD31- CD45- FRC have been 
described to regulate the homeostasis of naive T cells in the LN. Adipocyte 
precursor cells which are able to migrate to the LN anlagen to become part of the 
lymphoid stroma share characteristics with the LN FRC [Link et al. 2007, Bénézech 
et al. 2012]. In this study, the ability of Gp38+ ASCs to promote lymphocyte survival 
through involvement of the LTβR signalling pathway and expression of IL-7 was 
investigated ex vivo. 
 
4.1  Adipose tissue-derived SVF cells promote lymphocyte 
survival 
 
Lymphocyte survival was significantly enhanced by the presence of ASCs, although 
this effect was not as prominent in B cells. This observation is supported by 
Bénézech et al. 2012 and Link et al. 2007, who also found this effect to be specific 
to T cells, with B cell survival only minimally enhanced by the presence of ASCs. 
Link and co-workers found that IL-7 was produced mostly by Gp38+ stromal cells in 
the LN [Link et al. 2007], and cells with this phenotype can also be found in the SVF 
of adipose tissues [Bénézech et al. 2012]. 
            IL-7 can regulate both T and B cell survival [Taguchi et al. 2007, Tan et al. 
2001], but has been shown to mainly support T cell survival [Link et al. 2007, 
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Bénézech et al. 2012]. The fact that IL-7 can regulate B cell survival to some extent 
provides a possible explanation regarding the smaller yet still evident influence of 
ASCs on B cell survival. In addition to this, the numbers of FDC-like cells producing 
supportive B cells factors such as CXCL13 in the SVF may have been sparse 
compared to FRC-like cells supporting T lymphocytes, unlike the LN which is 
massively populated by FRC and FDC subsets. More FRC-like cells than FDC-like 
cells in the adipose tissue SVF would result in a greater enhancement of T cell 
survival than B cell survival due to the production of more T cell than B cell survival 
factors, and this was observed in Figure 3b. 
            CD4+ T cell survival was higher than CD8+ T cells in co-cultures with WT 
ASCs. A large overlap in stromal cell derived factors modulating CD4+ and CD8+ 
lymphocyte survival exists, for example, interleukin 21 (IL-21) and IL-7 can regulate 
both CD4+ and CD8+ T cells [Ostiguy et al. 2007, Rochman et al. 2009]. One 
feasible explanation for the observed difference in lymphocyte survival may be that 
the net effect of the factors secreted by ASCs in the SVF influenced CD4+ T cell 
survival to a greater extent than CD8+ T cells. Despite reports that CD8+ T cells 
have an innate ability to survive longer [Ferreira et al. 2000], it is unlikely that this is 
the cause of the descrepency in survival between T lymphocyte populations 
because survival decreased at approximately the same rate without ASCs, with 
CD4+ and CD8+ populations exhibiting similar decreases on day 2 of 81.6% and 
85.6% respectively. The observation that CD4+ T cells survived better than CD8+ T 
cells was not found by Link et al. 2007, where no difference between these subsets 
is observed. This may be due to their use of sorted FRCs, not ASCs, in co-culture. 
Adult murine SVF cells were used in this study as the source of ASCs, and were not 
sorted in the experiment shown in Figure 3. Therefore, it is likely that the SVF 
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contained a larger variety of stromal cells, not just FRC-like cells, producing a 
different profile of survival factors. 
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4.2 LTβR-/- stromal cells exhibit decreased ability to support 
lymphocyte survival 
 
LTβR-/- ASCs exhibited a decreased capacity to enhance the survival of 
lymphocytes in co-culture, but were still able to support survival to a greater extent 
than in the absence of any ASCs.  
            Similar to the findings of the prior assay (Figure 3b), only a minimal effect 
was seen on B cell survival in both co-culture with WT or LTβR-/- ASCs. This was 
most likely due to the same reasons as previously described in section 4.1; less B 
cell-supporting ASCs may have been present, and therefore fewer survival factors 
were available. B cell survival factors regulated by LβTR, such as BAFF (B cell 
activating factor) [Dejardin et al. 2002], would be reduced and therefore decrease B 
cell survival when co-cultured with LTβR-/- ASCs. Since B cells did not present with 
increased survival to the extent of T cells for both WT and LTβR-/- ASC co-cultures, 
it is possible that LTβR is not central to the regulation of B cell survival, and may not 
regulate the majority of B cell survival factors in adipose tissue. This could be 
confirmed by the investigation of WT and LTβR-/- expression of such factors in 
ASCs, and the presence of FDC-like CD35+ cells. 
            The involvement of LTβR in the differentiation of LN stromal cells has been 
demonstrated. LTβR engagement on pre-adipocytes inhibits adipocyte 
differentiation and promotes differentiation into LN stromal cells, and the expression 
of IL-7 [Bénézech et al. 2012]. A lack of signalling though LTβR can also result in 
the differentiation of ASCs into adipocytes, and therefore reduced IL-7 levels as 
decreased IL-7 production in adipocytes has been demonstrated by Maijer and co-
workers [Maijer et al. 2011], possibly contributing to the decreased levels of survival 
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seen in Figure 5b. Another feasible explanation for the decrease in survival of 
lymphocytes in co-culture with LTβR-/- ASCs is that these stromal cells may have 
been dying at a higher rate than WT ASCs due to a lack of LTβR-mediated 
signalling, and were therefore producing less IL-7, resulting in the decreased 
survival of lymphocytes. Oshima and co-workers found that CD4+ T lymphocytes 
express significantly high levels of LT, which in turn supports stromal cell survival 
through LTβR signalling [Oshima et al. 1999]. In a recent investigation [Zeng et al. 
2012], the depletion of CD4+ T cells resulted in significant loss of FRCs due to a 
lack of LTβR ligation by LT, further supporting the results seen in Figure 4b. The 
degree of which lymphocyte subsets affect ASC survival could be further 
investigated though co-culture of CD4+, CD8+ and CD19+ lymphocytes individually, 
and monitoring of stromal cell survival. In vivo conditions would also allow the action 
of other factors and interactions promoting stromal cell survival, but this is an area 
of stromal cell research remaining to be explored.  
            A difference between CD4+ and CD8+ T cell survival was seen, with CD4+ T 
cells appearing to survive the best with or without WT or LTβR-/- ASCs. Once again, 
this could be attributed to the cocktail of survival factors produced by ASCs 
favouring CD4+ T cells. 
            Despite a lack of LTβR signalling, significant lymphocyte survival was still 
observed suggesting the involvement of other signalling pathways or activation of 
other receptors regulating genes which support lymphocyte survival or intrinsic 
regulation of stromal cell activities and fate, for example TNF-α [Meijer et al. 2011]. 
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4.3 Pre-adipocyte-derived IL-7 supports T lymphocyte survival 
 
Since pre-adipocytes share similar characteristics with FRCs, it was investigated 
whether it was the Gp38+ adipocyte precursor cells which were responsible for the 
enhancement of lymphocyte survival in co-cultures.  
            No significant effects were observed under any culture conditions for B cells, 
suggesting that pre-adipocytes and IL-7 do not play an essential role in the survival 
of B lymphocytes. The remaining levels of B cell survival could reflect the minor 
support provided by pre-adipocyte derived IL-7, or the secretion of a different factor 
such as BAFF from Gp38+ CD31- CD45- CD35+ FDC-like cells [Hase et al. 2004, 
Link et al. 2007] which, if present, would not have been eliminated from the cell sort 
on the basis of CD35 expression. 
            However, T lymphocyte survival was enhanced by co-culture with sorted 
Gp38+ pre-adipocytes, and was significantly increased in CD8+ T cells, 
demonstrating the involvement of pre-adipocyte cells in lymphocyte survival. 
Inhibition of IL-7 using an antibody directed against the alpha chain of the IL-7R 
lead to a significant decrease in CD4+ and CD8+ T lymphocyte survival in the 
presence of pre-adipocytes. This strongly suggests that T cell survival is dependent 
on IL-7, and that it is most likely to be pre-adipocytes producing this factor. These 
observations are supported by the findings of Bénézech et al. 2012 who observed 
that Gp38+ pre-adipocytes produce IL-7, and inhibition of this leads to decreased 
lymphocyte survival. 
            Further supporting the idea that pre-adipocytes are producing IL-7 which is 
enhancing T cell survival are our findings that IL-7 is expressed in the SVF, and 
sorting of Gp38+ cells enriched IL-7 expression in this fraction. Similar levels of IL-7 
expression were observed in the SVF and adipocyte fractions, however on 
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purification, IL-7 expression was higher despite removal of other cells in this 
fraction. This was also higher then IL-7 expression in the LN. Collectively these data 
suggest that Gp38+ cells in adipose tissue produce high levels of IL-7, and is the 
reason for T lymphocyte survival, supporting the previous findings that WT ASCs 
are able to support lymphocyte survival in co-cultures. 
            Interestingly, complete inhibition of lymphocyte survival was not observed 
despite the addition of anti-IL-7Rα, suggesting that IL-7 is not independently 
supporting survival, but that other factors are also involved. This supports the  
LTβR-/- ASC survival assay as despite a lack of LTβR signalling, and likely decrease 
in IL-7 production, survival of lymphocytes still occurred. This survival could be 
attributed to the expression of the chemokine CCL19, which was expressed by 
ASCs (Figure 5b). In future, the synergistic effect of IL-7 and CCL19 on lymphocyte 
survival should be investigated to determine pre-adipocyte derived CCL19 
involvement, and examine whether synergy results in even higher levels of 
lymphocyte survival in co-culture with pre-adipocytes, and whether inhibition of both 
factors can significantly knock this down. 
            IL-7 and CCL19 are two major factors contributing to lymphocyte survival in 
LN. The ability of purified Gp38+ pre-adipocytes to express IL-7 and CCL19 was 
confirmed by RT-PCR, and was detectable at physiologically relevant levels in both 
WT and LTβR-/- SVF, suggesting that their expression is not dependent on LTβR. 
However, defective survival of T cells in co-culture with LTβR-/- ASCs suggests that 
other factors must be involved in their survival which do not involve LTβR signalling, 
again, supporting the idea that pre-adipocytes are capable of supporting T cell 
survival. 
            FRCs support T cell survival in LNs and present with a similar phenotype to 
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pre-adipocytes, producing CCL19 and IL-7.  Therefore, pre-adipocytes may share 
similar functions in adipose tissue, hence enhanced T cell survival. This is feasible 
because FRCs do not support B cell survival to the extent of T cell survival, and this 
was seen in all survival assays.  
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4.4. Stromal cell populations are similar in WT and LTβR-/- SVF 
from adipose tissue 
 
In order to confirm that defects in the stromal cell compartment of adipose tissue 
were not responsible for the diminished ability of LTβR-/- ASCs to support 
lymphocyte survival, three samples of adipose tissue from each group were 
individually digested and stained as described. No apparent differences in the 
percentage of cells in each gate from WT and LTβR-/- groups were observed, except 
in the Gp38+CD31- gate, where the WT fraction was 44.3% and the LTβR gate 
contained 57.1% cells (i.e. pre-adipocytes). However, due to the smallness of this 
difference, it is most likely to reflect individual variance between animals, and is not 
the cause of differential lymphocyte survival. 
 
 
 
 
 
 
 
 
 
	  	   86 
4.5 Conclusion & future implications 
 
Stromal cells provide indispensible support to immune cells, providing them with 
optimal environments to respond to antigens. This investigation and others [Link et. 
al 2007, Bénézech et al. 2012] have demonstrated this supportive ability, which is 
particularly important to T cells.  
            T cell survival was shown to be dependent on ASC expression of IL-7, which 
was enriched following cell sorting of Gp38+ CD31- CD45- pre-adipocytes. Adipose 
tissue-derived pre-adipocytes with phenotypic characteristics of FRCs were 
demonstrated to express lymphotrophic factors IL-7 and CCL19, however, the 
results strongly suggest that survival factors other than IL-7 must also be involved, 
as lymphocyte survival remained despite inhibition of IL-7R signalling. 
            Stromal cell LTβR was shown to be linked to lymphocyte survival as a lack 
of LTβR signalling correlated with a decrease of lymphocyte survival in co-cultures. 
However, some T cell survival remained, and LTβR-/- SVF cells were able to 
express IL-7 and CCL19, suggesting that other signalling is involved which is 
independent of LTβR. 
            Adipose tissue is known to be highly metabolic, and many lymphocytes are 
retained here, although the reason for this is unknown. Lymphocytes are able to 
communicate with adipose tissue through LT expression and adipose tissue LTβR, 
and can respond to adipose tissue-secreted factors such as adipokines [reviewed in 
Caspar-Bauguil et al. 2009]. Thus, it is possible that a dialogue exists between 
lymphocytes, adipose tissue and the cells contained in the SVF. Some 
understanding of the effects of adipose tissue on lymphocytes exists, but the effect 
of lymphocytes on adipose tissue is less well studied. Adipose tissue regulates 
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lymphocyte survival via IL-7, and lymphocytes can inhibit adipocyte differentiation 
thought LTβR signalling, suggesting a reciprocal relationship. Lymphocyte numbers 
differ greatly depending on obesity, metabolic state and inflammation [reviewed in 
Caspar-Bauguil et al. 2009], suggesting possible regulation of metabolic activities in 
adipocytes. In order to uncover the mechanisms by which lymphocytes regulate 
adipose tissue and the possible dialogue which exists between them, further 
investigation is required. 
            Although it is clear that ASCs are involved in the regulation of lymphocyte 
survival, the exact mechanisms are unknown. Future studies into the mechanisms 
underlying the support of lymphocyte survival by ASCs such as pre-adipocytes will 
lead to a better understanding of adipose tissue as an immunological organ. 
Investigation of the supportive capacity of other factors produced by pre-adipocyte 
may provide insight into the global signalling networks governing lymphocyte 
survival in adipose tissue. LTα-/- mice could be used to determine whether similar 
effects in ASCs from these animals lacking the function ligand are seen in LTβR-/- 
animals, and further examine the involvement of LTβR in the survival of both ASCs 
and lymphocytes. In ex-vivo studies, pre-adipocytes are cultured in a closed 
system, out of context of their physiologically normal stromal environment in vivo, 
where many other influencing factors are present which are not represented in vitro 
experiments. Therefore, the development of in vivo models may facilitate the 
comprehension of the vast array of factors and interactions involved in stromal cell 
and lymphocyte survival in adipose tissues. In doing so, the pathological 
mechanisms of disorders involving lymphocyte dysregulation such as autoimmunity, 
or the low-grade state of chronic inflammation associated with obesity, can be better 
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recognised, possibly leading to the development of novel therapies involving 
stromal cells or their associated mediators.  
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